SciSight Ecosystem
WoS ESCI Q4Scopus Q4SCImago #23,910CAS 4区Hybrid

Astim Allerji Immunoloji

Country: Turkey•WoS SCIE Quartile: Q4•Scopus SJR: 0.17•SCImago Rank: #23,910•Identifier (ISSN):1308-9234(Print)•Articles / Year: 28•Estimated Publication Fee (APC): $2,346 USD
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)Q4
0.4
– 0

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (Hirsch Index)
6

6 papers with at least that number of citations each

WoS: ESCIQ4
Self-Citation RateN/A
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
28articles/year
79.37% Gold OA•93.75% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q4(IF: 0.4)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.00đ
WoS Q4(IF: 0.4)
🔵 Computed
20251.00đ
WoS Q4(IF: 0.4)
🔵 Computed
20241.00đ
WoS Q4(IF: 0.3)
🔵 Computed
20231.00đ
WoS Q4(IF: 0.2)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Asthma Allergy Immunology has been published three times a year in April, August and December as the official and periodical journal of the Turkish National Society of Allergy and Clinical Immunology since 2003. All articles published in the journal have been available online since 2003. A peer reviewed system is used in evaluation of the manuscripts submitted to Asthma Allergy Immunology. The official language of the journal is English. The aim of the journal is to present advances in the field of allergic diseases and clinical immunology to the readers. In accordance with this goal, manuscripts in the format of original research, review, case report, articles about clinical and practical applications and editorials, short report and letters to the editor about allergic diseases and clinical immunology are published in the journal. The target reader population of the Asthma Allergy Immunology includes specialists and residents of allergy and clinical immunology, pulmonology, internal medicine, pediatrics, dermatology and otolaryngology as well as physicians working in other fields of medicine interested in allergy and immunological diseases.

Topics Covered (Recognized by AI)
MedicineBiologyImmunologyInternal MedicinePathologyGeneticsAllergyPsychologyChemistryPathology & Diseases
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #23,910Scopus Q4SCImago Profile
Scopus Coverage:2014-2016, 2019-2025
Scopus Broad Areas:Immunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q4
0.17

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q4
Scopus H-Index (2025)
6

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
0.52

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,346 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations61
3-Year Documents123
Citable Documents107

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate62.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

ImmunologyQ4
Immunology and AllergyQ4
Pulmonary and Respiratory MedicineQ4

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ALLERGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Bilimsel Tip Yayinevi
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
ALLERGY
JCRESCI
35/40Q4
ALLERGY
JCIESCI
34/40Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

11 year
YearImpact FactorArticles / YearTotal Citations
2026—161
20250.44913
20240.34940
20230.24068
2022—2243
2021—2838
2020—3459
2019—1851
2018—1622
2017—4067
2016—2735
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Astim Allerji Immunoloji

WoS Q4
00112023202420250.40
Annual Impact Factor Metric
2025:0.4

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 4bed7efd-c7d4-47be-a5ba-91994e80c81f
Database Updated: 2026-09-28